ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

CUSIP: 682310875

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock, no par value
Shares outstanding
109,272,143
Total 13F shares
391,100
Share change
-182,134
Total reported value
$223,581
Price per share
$0.58
Number of holders
12
Value change
-$568,195
Number of buys
7
Number of sells
5

Security key

682310875

Report period

Q3 2019

Institutions

12

Top holders

10

Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Verition Fund Management LLC
13F
Company
0.37%
408,838
$695,000 30 Jun 2019
13F
MORGAN STANLEY
13F
Company
0.05%
56,460
$97,000 30 Jun 2019
13F
SCOTIA CAPITAL INC.
13F
Company
0.04%
48,039
$83,000 30 Jun 2019
13F
COMERICA BANK
13F
Company
0.01%
15,526
$26,000 30 Jun 2019
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
11,304
$19,000 30 Jun 2019
13F
Magnus Financial Group LLC
13F
Company
0.01%
10,000
$17,000 30 Jun 2019
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0.01%
7,985
$13,780 30 Jun 2019
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
6,582
$11,000 30 Jun 2019
13F
DEUTSCHE BANK AG\
13F
Company
0%
4,600
$7,000 30 Jun 2019
13F
NEXT Financial Group, Inc
13F
Company
0%
1,472
$3,000 30 Jun 2019
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
1,390
$3,000 30 Jun 2019
13F
HUNTINGTON NATIONAL BANK
13F
Company
0%
1,052
$2,000 30 Jun 2019
13F
UBS Group AG
13F
Company
0%
734
$1,000 30 Jun 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
642
$1,000 30 Jun 2019
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0%
440
$1,000 30 Jun 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
367
$1,000 30 Jun 2019
13F

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q3 2019

As of 30 Sep 2019, ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 391,100 shares. The largest 10 holders included MORGAN STANLEY, SCOTIA CAPITAL INC., RENAISSANCE TECHNOLOGIES LLC, Magnus Financial Group LLC, CITADEL ADVISORS LLC, COMERICA BANK, DEUTSCHE BANK AG\, ROYAL BANK OF CANADA, Federation des caisses Desjardins du Quebec, and BANK OF MONTREAL /CAN/. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
13
Q3 2019 holders
12
Holder diff
-1
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .